# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA883130 | F | In vitro effective concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line | Hepatitis B virus | 18 | ALA1137080 | organism-based format | Scientific Literature | |
2. | ALA615331 | F | Inhibition of the replication of HBV in 2.2.15 cells, by DNA hybridization assay | Hepatitis B virus | 17 | ALA1136768 | organism-based format | Scientific Literature | |
3. | ALA665683 | F | In vitro antiviral activity against duck hepatitis B virus (DHBV) | Hepatitis B virus | 2 | ALA1134840 | organism-based format | Scientific Literature | |
4. | ALA691469 | F | Antiviral activity against Hepatitis B virus (HBV) in 2.2.15 cells | Hepatitis B virus | 14 | ALA1133470 | organism-based format | Scientific Literature | |
5. | ALA691470 | F | Antiviral activity against HBV; No data | Hepatitis B virus | 1 | ALA1127652 | organism-based format | Scientific Literature | |
6. | ALA691471 | F | Antiviral activity was assessed against HBV in hepatoma cell line 2.2.15; inactive | Hepatitis B virus | 11 | ALA1132748 | organism-based format | Scientific Literature | |
7. | ALA691472 | F | Antiviral activity was assessed against HBV in hepatoma cell line 2.2.15; inactive | Hepatitis B virus | 5 | ALA1132748 | organism-based format | Scientific Literature | |
8. | ALA691473 | F | Ability to reduce the viral DNA in HBV infected primary duck hepatocytes to 50% | Hepatitis B virus | 13 | ALA1134633 | organism-based format | Scientific Literature | |
9. | ALA691474 | F | Antiviral activity against Hepatitis-B virus 2.2.15(HBV) | Hepatitis B virus | 7 | ALA1130219 | organism-based format | Scientific Literature | |
10. | ALA691476 | F | Tested for inhibition against hepatitis B virus (HCV) in cultured human hepatoblastoma 2.2.15 cells | Hepatitis B virus | 1 | ALA1145091 | organism-based format | Scientific Literature | |
11. | ALA691477 | F | In vitro inhibitory activity against proliferation of HBV viral cell | Hepatitis B virus | 2 | ALA1131400 | organism-based format | Scientific Literature | |
12. | ALA693665 | F | Concentration inhibiting the replication of HBV in HFF cells by plaque reduction assay | Hepatitis B virus | 17 | ALA1136768 | organism-based format | Scientific Literature | |
13. | ALA698450 | F | Cytotoxic activity was determined against Hepatitis B virus (HBV) at 10 uM using HepG2-derived 2.2.15 cell lines | Hepatitis B virus | 2 | ALA1134806 | organism-based format | Scientific Literature | |
14. | ALA872001 | F | Inhibitory activity was determined against Hepatitis B virus (HBV) at 10 uM using HepG2-derived 2.2.15 cell lines | Hepatitis B virus | 2 | ALA1134806 | organism-based format | Scientific Literature | |
15. | ALA690915 | F | Activity of compound against hepatitis B virus was determined; IA means inactive | Hepatitis B virus | 1 | ALA1147600 | organism-based format | Scientific Literature | |
16. | ALA690916 | F | Compound was evaluated against hepatitis B virus; IA means inactive | Hepatitis B virus | 4 | ALA1147600 | organism-based format | Scientific Literature | |
17. | ALA690917 | F | Tested for cytotoxic concentration against hepatitis B virus | Hepatitis B virus | 1 | ALA1130554 | organism-based format | Scientific Literature | |
18. | ALA879579 | F | Compound concentration required to inhibit the viral cell proliferation by 50% against HBV | Hepatitis B virus | 4 | ALA1130851 | organism-based format | Scientific Literature | |
19. | ALA695318 | F | Concentration required to inhibit 50% of Hepatitis B virus replication | Hepatitis B virus | 10 | ALA1132735 | organism-based format | Scientific Literature | |
20. | ALA695963 | F | Concentration required to inhibit 50% of Hepatitis B virus replication; not determined | Hepatitis B virus | 1 | ALA1132735 | organism-based format | Scientific Literature |